EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 29-Oct-2025 06:11 ET (29-Oct-2025 10:11 GMT/UTC)

5-Jun-2025

43,000 data points against melanoma: data-driven personalized treatments are about to become a reality

University of Zurich
Peer-Reviewed Publication

Every tumor is unique. This makes it difficult to find the most effective therapy for treatment. The Tumor Profiler Center of the University Hospital Zurich, the University of Zurich, ETH Zurich and the University Hospital Basel has now carried out a study in which nine different molecular biological technologies were used to precisely measure the properties of the tumor in four weeks and enable a precise treatment decision. The study is the first of its kind in the world.

Journal: Nature Medicine

5-Jun-2025

Cancer treatments should be licensed for all ages, oncologists say

Cell Press
Peer-Reviewed Publication

Recent advances have resulted in highly effective “tissue-agnostic” drugs that treat cancers based on their molecular markers rather than their tissue of origin, but very few of these drugs are approved for use in children. In an opinion paper publishing June 5 in the Cell Press journal Trends in Cancer, oncologists call for “ag(e)nostic” cancer treatments: drugs that are both tissue agnostic and approved for cancer patients of all ages.

Journal: Trends in Cancer
Funder: American Cancer Society, MCW Cancer Center, Pediatric Transplantation and Cellular Therapy Consortium, Jeff Gordon Children’s Foundation

5-Jun-2025

BMI, physical activity, and subsequent neoplasm risk among childhood cancer survivors

JAMA Network
Peer-Reviewed Publication

About The Study: Among childhood cancer survivors in this cohort study, obesity was associated with an increased risk for multiple subsequent neoplasm types, while higher physical activity was associated with reduced subsequent neoplasm risk. Lifestyle interventions should be considered in future subsequent neoplasm prevention research.

Journal: JAMA Oncology

5-Jun-2025

Colorectal cancer screening via smartphone?

German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Peer-Reviewed Publication

Colorectal cancer screening programs are currently underutilized in Germany. This also applies to testing for blood in the stool. The immunological stool tests can detect tiny amounts of blood in the stool. Scientists at the German Cancer Research Center (DKFZ) have investigated whether smartphone-based testing could be a meaningful alternative or supplement to traditional laboratory tests.

Journal: Clinical Gastroenterology and Hepatology

5-Jun-2025

NRG Oncology study shows the addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence in patients whose axillary nodes convert from positive to negative following neoadjuvant chemotherapy

NRG Oncology
Peer-Reviewed Publication

Recent results from the NRG-NSABP B-51/RTOG 1304 clinical study showed that the addition of regional nodal irradiation (RNI) does not decrease the rates of invasive breast cancer recurrence in patients whose positive axillary nodes at presentation convert to negative following neoadjuvant chemotherapy. These results were recently published in the New England Journal of Medicine.

Journal: New England Journal of Medicine

5-Jun-2025

Brain care score strongly correlates with risk of cardiovascular disease and three most common cancers worldwide

Mass General Brigham
Peer-Reviewed Publication

A new study from researchers at Mass General Brigham has found that a higher McCance Brain Care Score not only associates with the risk of brain-related conditions such as stroke, dementia, and depression but also strongly associates with developing cardiovascular disease and three common types of cancer.

Journal: Family Practice
Funder: NIH/National Institutes of Health, American Heart Association

5-Jun-2025

ESMO Gynaecological Cancers Congress 2025: Event announcement

European Society for Medical Oncology
Meeting Announcement

The ESMO event dedicated to advancing the understanding, management, and treatment of gynaecological malignancies

5-Jun-2025

Biweekly dose of TAS-102 reduces toxicity and remains effective for treatment of colorectal cancer, says study

Temple University Health System
Peer-Reviewed Publication

Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw similar treatment effectiveness and reduced toxicity compared with treatment using standard dosing schedules, according to a recent study in The Oncologist that was co-authored by a Fox Chase Cancer Center physician.

Journal: The Oncologist

5-Jun-2025

MET mutation and cancer immunity

Compuscript Ltd
Peer-Reviewed Publication

Immunotherapy is a revolutionary cancer treatment strategy that leverages the body’s immune system to fight cancer. While immune checkpoint inhibitors significantly improve the therapeutic outcomes in many tumors, most cancer patients cannot benefit from these.

Journal: Genes & Diseases
Funder: National Natural Science Foundation of China

5-Jun-2025

Reduction in length of immunotherapy treatment for hard-to-treat melanoma shows promise in clinical trial

University of Sheffield
Peer-Reviewed Publication

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control when compared to giving treatments over a longer period, according to breakthrough research led by the Universities of Sheffield and Leeds and Sheffield Teaching Hospitals NHS Foundation Trust.

Journal: Journal of Clinical Oncology
Meeting: 2025 ASCO Annual Meeting